Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34417512)
Watch
English
Multiplicity in randomised trials II: subgroup and interim analyses
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
title
Multiplicity in randomised trials II: subgroup and interim analyses
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
author
David Grimes
series ordinal
2
object named as
David A Grimes
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
author name string
Kenneth F Schulz
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
language of work or name
English
0 references
publication date
1 May 2005
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
volume
365
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
issue
9471
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
page(s)
1657-1661
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
cites work
Multiplicity in randomised trials I: endpoints and treatments.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
From star signs to trial guidelines.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interaction revisited: the difference between two estimates
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Subgroup analysis and other (mis)uses of baseline data in clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
What's wrong with Bonferroni adjustments
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prevention of preterm birth in high-risk patients: the role of education and provider contact versus home uterine monitoring
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
When to stop a clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Multiple Testing Procedure for Clinical Trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sequential stopping rules in clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sample size calculations in randomised trials: mandatory and mystical
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interim analysis: the alpha spending function approach.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Refining clinical diagnosis with likelihood ratios
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Applying Bayesian ideas in drug development and clinical trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The what, why and how of Bayesian clinical trials monitoring.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monitoring of large randomised clinical trials: a new approach with Bayesian methods
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(05)66516-6
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
PubMed ID
15885299
1 reference
stated in
Europe PubMed Central
PubMed ID
15885299
retrieved
2 August 2017
ResearchGate publication ID
7856449
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
